@surgery_hps Surg Fellow, @EurPancClub Postgraduate, @AcoAsso Scholar, @Harvardmed Postdoc, @UniklinikHD Graduate, @UniHeidelberg Alum, German 🇩🇪.
Heidelberg, Germany
Joined November 2022
- Tweets125
- Following301
- Followers402
- Likes1K
Thomas Hank, MD retweeted
Temporary venous bypass may facilitate complex pancreatic tumor resections with extensive vascular involvement, with mesoportal bypass favored when hepatic arterial resection is also required. ovid.com/10.1097/SLA.0000000…
Thomas Hank, MD retweeted
🇪🇺Europe is stepping up in the treatment of
#PancreaticCancer with the first Multidisciplinary #Guidelines and the #PALACROS project 🔥
🤝Involving over 30 societies and patient organizations, 15 countries and 60+ centers across Europe
🙌Thanks to @my_ueg (14,000+ attendees!) for highlighting these developments!
🔗#PALACROS including the #PREOPANC4 RCT #PULSE and #PIVOTAL trials: pancreaticcancereurope.eu/pr…
🔗#Guidelines protocol: pancreaticcancereurope.eu/pr…
Thomas Hank, MD retweeted
#PALACROS kick-off in @AmsterdamUMC
🙌We welcomed 46 colleagues from 26 organisations across 12 countries for our first in-person consortium meeting
🔥Our mission: Improve and expand effective #surgical treatment for patients with locally advanced #pancreaticcancer across #Europe.
✅9 work packages, 3 RCTs incl #PREOPANC4 #PULSE #PIVOTAL @OncoSil @oncolyze and surgical training for 6 countries 🇬🇧🇦🇹🇵🇱🇱🇹🇪🇪🇱🇻 and Al radiology LAPC detection and classification
@ThomasHankMD @gimalleo @DenaZade
🔗pancreaticcancereurope.eu/pr…
amsterdamumc.org/en/research…
Thomas Hank, MD retweeted
It did happen🎉@PALACROSeu has the potential to shape the future of pancreatic surgery! Thanks to @MarcBesselink and @ThomasHankMD for co-leadership, thanks to @SalviaRobi for continued mentorship, thanks to @ga3lion and @DenaZade ❤️ for making it possible! @HorizonEU @UniVerona
What a honor to coordinate a 10-million euros project on locally advanced pancreatic cancer with @amsterdamumc and @surgery_hps, funded by the @HorizonEU! @PALACROSeu will establish harmonised standards and expand access to specialised pancreatic surgery. univrmagazine.it/2026/07/07/…
Excited to kick off #PALACROS - a €10 million horizon Europe project bringing together experts across 🇪🇺 to improve surgical care and outcomes for patients with locally advanced pancreatic cancer.
Looking forward to the journey 🚀
@uniklinik_hd @hd @surgery_hps
#PALACROS receives a €10 million Horizon @EU_Commission grant to improve surgical and oncological treatment for patients with locally advanced #pancreaticcancer through clinical trials, standardised decision-making, surgical training, Al-supported patient identification, and strong patient involvement.
@MarcBesselink @gimalleo @ThomasHankMD @IngmarFRompen @TFStoop @i_verpalen @Gio_Marchegiani @EAHPBA @my_ueg @P_C_E_ amo
amsterdamumc.org/en/research…
Thomas Hank, MD retweeted
🔴 Post-Pancreatectomy liver injury (PPLI) might be a new significant entity in the modern era of pancreas cancer surgery with vascular resection
👉 Incidence 13% leading to ⬆️ mortality
🔜 More to come!
sciencedirect.com/science/ar…
Thomas Hank, MD retweeted
#HoraEst 🎓 @IngmarFRompen today @UvA_Amsterdam “Extended indications for #pancreatic #surgery (#promotie). Well done Ingmar!!
➡️ dare.uva.nl/id/9c78faf9-53e8…
🎯Amazing thesis including 14 chapters, all published, including 9x(!!) @AnnalsofSurgery. Thanks to all 99 co-authors from 🇩🇪🇺🇸🇳🇱 🇮🇹🇳🇴🇸🇪🇫🇮🇩🇰🇬🇧🇯🇵
✅ Wonderful collaborative PhD team @MarcBesselink @cw_michalski 🇩🇪 @cwolfga2 🇺🇸 @ammar_asrar 🇺🇸 @DPCG_official
Thanks to the excellent committee including @Gio_Marchegiani @TFStoop @i_verpalen @HenrikNien
Thomas Hank, MD retweeted
In a meta-analysis of pancreatoduodenectomy, broader antibiotic prophylaxis was associated with fewer infectious complications, suggesting broader coverage may represent a potential new standard. journals.lww.com/annalsofsur…
Thomas Hank, MD retweeted
Postpancreatectomy diarrhoea 🔴🔴 an emerging issue in the era of pancreas cancer surgery
🚨Incidence 33% at 90 days
😖 Severity correlates with QoL
💊 PERT always required + 40% loperamide
✂️ Arterial divestment / vascular resection risk factors
academic.oup.com/bjsopen/art…
Thomas Hank, MD retweeted
Broad-spectrum antibiotic prophylaxis reduced infectious complications after pancreatoduodenectomy, particularly among patients with preoperative biliary drainage. journals.lww.com/annalsofsur…
In Freiburg for the 45th Annual Meeting of the German Pancreas Club 🇩🇪
Strong @surgery_hps with talks on
✂️ Arterial Divestment benchmark outcomes
🦠 Microbiome changes in head vs body tumors
📈 Updated observed 5-year survival
🔬 Complete pathological response
🩸 PPH
Thomas Hank, MD retweeted
Oligometastatic pancreatic cancer 🔴 finally defined in @TheLancetOncol
🥇thelancet.com/journals/lanon…
🧐 What about treatment?!
😉 Join our ongoing RCT SONAR 📡 link.springer.com/article/10…
Thomas Hank, MD retweeted
Postpancreatectomy 🩸 hemorrhage: risk factors and outcomes
🔎 10k pts 🆎 PPH 6% / motality 3% bothe increasing with complexity
PPH increased 🔟 fold mortality especially if 🔪 relaparotomy 🌱 bleeding from HA / SMA ⏱️ late bleeding
journals.lww.com/annalsofsur…
Very early recurrence after surgery remains a major unmet challenge in pancreatic cancer 🎯
Prognostic factors for very early recurrence after neoadjuvant treatment and curative resection in pancreatic ductal adenocarcinoma surgjournal.com/article/S003… thank you @ThomasHankMD for your outstanding @SurgJournal contribution
Fantastic #EPC2025 meeting in Düsseldorf 🇩🇪 with so many good friends @EurPancClub
🔥 session on multimodal therapy for locally-advanced PDAC with advanced pancreatic surgery 📶
Thanks to @IEspositoPATH 💜
@surgery_hps @cw_michalski
Thomas Hank, MD retweeted
Prof Buchler @ChampalimaudF gives his “Lessons For Young Surgeons” and his “Lessons For The Teachers” at the @EurPancClub #EPC2025. A living legend 👑 in #Pancreas #Surgery
Thomas Hank, MD retweeted
Is it possible to attend 4️⃣ LAPC cases simultaneously?! 🙈
Yes… Only at @surgery_hps 🇩🇪 !!!
A unique team led by @cw_michalski paving the way to treat pancreas cancer in a modern fashion, from biology 🧬 to extreme surgery 🪡
Thank you for having me… again!
Thomas Hank, MD retweeted
📊 Smarter stratification for pancreatic cancer care: This multicenter study validated the PANAMA score to predict both survival and who should get chemo after FOLFIRINOX and surgery.
🔗journals.lww.com/annalsofsur…
A step further to individualized treatment in pancreatic cancer 🎯 - prospective validation in progress 🔜💥
Great team effort by @EAHPBA @cw_michalski @MarcBesselink @IngmarFRompen @surgery_hps
Pancreatic cancer patients aren't all the same. 🧬 The PANAMA score identifies who really benefits from post-op chemo after FOLFIRINOX—saving some from unnecessary treatment.
🔗journals.lww.com/annalsofsur…
Fantastic grand lecture by @FelixAigner2 👌🏻
#DanceintoMay – the #surgical way 🏥
🔍 with precision,
🤝 teamwork, and a shared commitment to #learningtogether 🤓🤓
and from one another.
This is how progress happens, in the OR and beyond!
@FelixAigner2
@cw_michalski
#SurgicalEducation #TeamworkInMedicine
